Xconomy: Sangamo Biosciences News, Articles and Opinions

“sangamo-biosciences” Archives

Entry	Author	Date	Location
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups	Ben Fidler	07/27/18	National
Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M	Ben Fidler	07/23/18	San Francisco
Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North	Ben Fidler	05/23/17	Boston
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More	Alex Lash	05/12/17	National
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More	Ben Fidler	08/05/16	National
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug	Ben Fidler	08/03/16	Boston
At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy	Ben Fidler	07/28/16	National
Sean Parker To Fund CRISPR Trial, And Other Gene Edit Milestones	Alex Lash	06/20/16	National
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes	Alex Lash	06/03/16	National
Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance	Ben Fidler	05/16/16	Boston
Across The Board: Ideas To Narrow Biotech’s Gender Gap	Alex Lash	05/10/16	National
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist	Ben Fidler	05/02/16	Boston
With CRISPR in Humans On The Horizon, Will the Public Back Intellia?	Alex Lash	04/29/16	Boston
Making the Price Right: Ideas To Change Drug Costs Gain Momentum	Alex Lash	04/05/16	National
Gene Editing Execs Talk Scientific, Regulatory Hurdles At BIO Panel	Ben Fidler	02/10/16	Boston
CRISPR: The Path to Clinical Trials	Alex Harding	01/29/16	Boston
UniQure’s Shares Rise on Early Gene Therapy Data For Hemophilia	Ben Fidler	01/07/16	National
Boston Scientists Tweak CRISPR Scissors For More Precise DNA Cuts	Alex Lash	01/06/16	Boston
Stewart Parker: Biotech Thoughts On Gene Therapy, GOP & Trout Streams	Alex Lash	12/31/15	Seattle
Pharmabros, Designer Babies, And Other Final Words For 2015	Alex Lash	12/24/15	National
Gene Edit Summit Leaders Stop Shy Of Call To Ban Germline Changes	Alex Lash	12/03/15	National
New Speakers Join Gene-Edit, Microbiome, Big Data “Disruptors” 12/10	Alex Lash	12/02/15	San Francisco
Agenda Posted: Xconomy’s Bay Area Life Science Disruptors On Dec. 10	Alex Lash	11/19/15	San Francisco
Join Xconomy Dec. 10 To Hear From Bay Area Life Science Disruptors	Alex Lash	11/12/15	San Francisco
Amid Nobel Prize Suspense, Making Sense Of Latest Gene-Editing News	Alex Lash	10/06/15	National
CRISPR Update Could Make Gene Edits Easier, Discoverers Say	Alex Lash	09/25/15	Boston
Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue	Ben Fidler	09/14/15	Boston
West Coast Biotech Roundup: Amgen, Grizzlies, Topol, Faraday & More	Alex Lash	09/03/15	San Francisco
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo	Ben Fidler	09/02/15	San Francisco
100 Years But Only One Drug: Sickle Cell Patients Wait For Help	Alex Lash	08/18/15	National
Page 1 of 3	next page »